Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...
WAUSAU, Wis. (WSAW) - While we do not know the reason behind each drunk driver’s choice to drive under the influence, we can look into some of the factors that play a role, like Alcohol Use Disorder ...
Researchers used positron emission tomography, or PET, brain imaging on 32 people with AUD and 29 controls. They found 11% ...
Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...
Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...
Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...
Pemvidutide is a novel, peptide-based GLP-1/glucagon dual receptor agonist. The Food and Drug Administration (FDA) has granted Fast Track designation to pemvidutide for the treatment of alcohol use ...
Please provide your email address to receive an email when new articles are posted on . Pharmacotherapy appears to be underused in alcohol use disorder, especially among those with related liver ...
Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...
A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths ...
Last spring, I treated a patient who was readmitted with a known severe alcohol use disorder. His withdrawal did not follow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results